Enhance surveillance and reporting systems for flu, RSV, and measles to ensure timely public health responses.
Pandemics
Viewed record
Moderate Risk
History
338 daily observations
Method
Curated sources and AI scoring
Pandemics Risk
3.7 / 5
Moderate Risk
-0.3 from previous reading
Assessment for this date
Today's pandemic risk is moderate due to rising flu, RSV, and measles cases, alongside persistent COVID-19 challenges and vaccine hesitancy.
Record date
December 24, 2025
Trend
Viewing the record for December 24, 2025 within the full trend.
Risk Drivers
What is pushing the current reading.
The current global health landscape is characterized by a resurgence in flu and RSV cases in the US and Europe, significant measles outbreaks, and ongoing COVID-19 challenges, including long COVID and vaccine hesitancy. Despite advancements in vaccine development and deployment, such as the updated COVID-19 vaccines and experimental mRNA flu vaccines, there are gaps in vaccination coverage and public health responses. Misinformation and regulatory challenges further complicate the situation, as seen in debates over vaccine safety and efficacy. These factors, combined with the emergence of other infectious diseases like avian flu and MERS, underscore a moderate risk level that requires vigilant monitoring and proactive measures.
Risk Reduction Actions
Priority actions generated from the current analysis.
Increase public awareness campaigns to combat misinformation and encourage vaccination uptake across all age groups.
Accelerate the development and distribution of effective vaccines for emerging and re-emerging infectious diseases.
Support community-based initiatives to improve vaccine accessibility and address vaccine hesitancy.
Facilitate global collaboration to monitor and respond to cross-border outbreaks and emerging health threats.
Sources Monitored
Visible feeds used in this category's nightly run.
Selected Articles
Supporting articles referenced in the latest score.
- Study finds that despite broad COVID vaccine availability, COVID still deadlier than flu in hospitalized patients
- Flu, RSV activity rising in US and Europe, with major UK surge in flu cases
- US reps berate FDA head, demand data for proposed vaccine regulation changes, purported link to child deaths
- Fewer people are being vaccinated against respiratory diseases
- US measles outbreak tops 1,800 cases as respiratory illness surveillance returns
- US measles outbreak tops 1,800 cases as respiratory illness surveillance returns
- US COVID, flu, and RSV levels low but rising in many regions
- Former FDA heads, Sen Cassidy push back on FDA official’s claim of 10 COVID vaccine deaths